Study to evaluate safety and efficacy of Rimegepant in Migraine Prevention in children and adolescents >6 to <18 years of age.
If interested please call our Salt Creek Circle Location and ask to speak to Rosie 402-327-6069
Study to evaluate safety and efficacy of Rimegepant in Migraine Prevention in children and adolescents >6 to <18 years of age.
COVID-19 and Flu Swab Test Study Contact our Research Coordinator to ask
Phase III Study of live-attenuated respiratory syncytial virus (RSV) vaccine in healthy
Measles, mumps, rubella, varicella vaccine compared with ProQuad, administered in healthy children
24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Health Infants Given 4 Doses at